Bluejay Diagnostics, Inc. (BJDX) earnings
Quarterly results of Bluejay Diagnostics, Inc. as filed with the SEC: revenue, net income and earnings per share for each of the last 8 quarters, the latest results release and when the next one is expected.
Latest quarter: Q2 FY2026
In Q2 FY2026 (ended June 30, 2026) Bluejay Diagnostics, Inc. reported revenue of - and a net loss of $2.3M.
Diluted earnings per share were -$1.12.
Quarter by quarter
| Quarter | Revenue | vs year ago | Net income | EPS |
|---|---|---|---|---|
| Q2 FY2026 | - | - | -$2.3M | -$1.12 |
| Q1 FY2026 | - | - | -$1.9M | -$1.95 |
| Q4 FY2025 | - | - | -$1.4M | - |
| Q3 FY2025 | - | - | -$1.6M | -$1.01 |
| Q2 FY2025 | - | - | -$2M | -$5.64 |
| Q1 FY2025 | - | - | -$1.9M | -$13.46 |
| Q4 FY2024 | - | - | -$1.4M | - |
| Q3 FY2024 | - | - | -$1.5M | -$76.94 |
Results filings
- Quarterly report 10-Q
- Quarterly report 10-Q
- Quarterly results 8-K
Get an email when BJDX reports
Follow BJDX and we email you its next results the day they are filed, with the numbers explained.